Stockscreener 앱 받기
0.00732
4.50%
0.000315
전일 마감가:
$0.007
열려 있는:
$0.0077
하루 거래량:
34,413
Relative Volume:
0.90
시가총액:
$N/A
수익:
$1.67M
순이익/손실:
$-4.50M
주가수익비율:
-0.00067
EPS:
-10.9183
순현금흐름:
$-6.73M
1주 성능:
+4.50%
1개월 성능:
+4.50%
6개월 성능:
-74.69%
1년 성능:
-99.75%
1일 변동 폭
$0.00732
$0.0077
1주일 범위
$0.00732
$0.0077
52주 변동 폭
$0.0055
$0.031
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
명칭
Petros Pharmaceuticals Inc
전화
-
주소
-
Compare PTPI vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.00732 | 0 | 1.67M | -4.50M | -6.73M | -10.92 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.00B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.60B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 40.43B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 34.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 23.98B | 3.18B | 1.33B | 1.04B | 27.90 |
Petros Pharmaceuticals Inc 주식(PTPI)의 최신 뉴스
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - MSN
Petros Pharmaceuticals Transitions to Healthcare Technology with Proprietary Rx-to-OTC SaaS and SaMD Platform Targeting Self-Care Market 36 - Minichart
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Petros Pharmaceuticals (PTPI) details tech pivot, default fallout and cash strain - Stock Titan
Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Death Cross: Can Petros Pharmaceuticals Inc expand its profit margins2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
Rate Cut: Can Petros Pharmaceuticals Inc expand its profit margins2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Published on: 2026-04-07 04:40:22 - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Petros Pharmaceuticals Delays Annual 10-K Filing - TipRanks
Petros Pharmaceuticals (NASDAQ: PTPI) notifies SEC of delayed 2025 10-K filing - Stock Titan
Buybacks Report: Can Petros Pharmaceuticals Inc lead its sector in growthMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Chipmakers Recap: Can Petros Pharmaceuticals Inc lead its sector in growth2026 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Nasdaq Moves: How does Petros Pharmaceuticals Inc perform in inflationary periods2026 Earnings Impact & Accurate Technical Buy Alerts - baoquankhu1.vn
Wall Street Recap: How does Petros Pharmaceuticals Inc perform in inflationary periods2026 Update & Reliable Intraday Trade Plans - baoquankhu1.vn
Bearish Setup: Can Petros Pharmaceuticals Inc ride the EV waveWeekly Profit Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Short Covering: Can Petros Pharmaceuticals Inc expand its profit marginsShort Setup & Risk Controlled Daily Plans - baoquankhu1.vn
Short Squeeze: What is the next catalyst for Petros Pharmaceuticals IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Market Overview: Will Petros Pharmaceuticals Inc benefit from green energy policies2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Analyst Upgrade: What are FICOs earnings expectationsTrade Risk Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
VIX Spike: Does Petros Pharmaceuticals Inc offer margin of safetyQuarterly Growth Report & AI Forecasted Stock Moves - baoquankhu1.vn
Is Niagen Bioscience Inc. (OCD1) stock undervalued historically2026 Top Gainers & Safe Entry Trade Reports - Naître et grandir
Can Petros Pharmaceuticals Inc. stock attract ESG capital inflows2025 Growth vs Value & Advanced Swing Trade Entry Plans - Naître et grandir
Why LICN stock remains resilientWeekly Risk Summary & Technical Analysis for Trade Confirmation - Naître et grandir
Published on: 2026-03-07 09:03:33 - baoquankhu1.vn
Can Petros Pharmaceuticals Inc expand its profit margins2025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Aug Fed Impact: What is the next catalyst for Petros Pharmaceuticals IncJuly 2025 Setups & Smart Investment Allocation Tips - baoquankhu1.vn
CEO Moves: Can DOGZ outperform under higher oil pricesMarket Performance Report & Pattern Based Trade Signal System - baoquankhu1.vn
Tech Rally: Can Blockchain Coinvestors Acquisition Corp I Equity Warrant reach resistance levels soonJuly 2025 Reactions & Weekly High Return Opportunities - baoquankhu1.vn
U.S. Erectile Dysfunction Drugs Market Set for Continued Growth - openPR.com
Can Petros Pharmaceuticals Inc. lead its sector in growth2025 Trade Ideas & Safe Entry Zone Tips - mfd.ru
Head-To-Head Survey: Panbela Therapeutics (OTCMKTS:PBLA) and Virios Therapeutics (NASDAQ:VIRI) - Defense World
OR Royalties (OR) – Investment Analysts’ Recent Ratings Changes - Defense World
Petros Pharmaceuticals (NASDAQ:PTPI) versus Virpax Pharmaceuticals (NASDAQ:VRPX) Head-To-Head Contrast - Defense World
US Market Wrap: Whats the MACD signal for Petros Pharmaceuticals Inc2025 Major Catalysts & Stock Portfolio Risk Control - baoquankhu1.vn
Petro's Policies Are Decimating Colombia's Natural Gas Industry - Yahoo Finance
Does NTST offer margin of safetyGap Down & Real-Time Buy Zone Alerts - mfd.ru
Can Petros Pharmaceuticals Inc. weather a recessionQuarterly Growth Report & Low Drawdown Trading Techniques - mfd.ru
Gap Down: Should I buy Horizon Funds Landmark Liquidity Etf stock nowTrade Entry Summary & Short-Term Trading Alerts - baoquankhu1.vn
Can GSRT stock double in the next yearMarket Risk Summary & Reliable Entry Point Alerts - mfd.ru
Can NHPBP stock continue upward trendJuly 2025 Trends & Verified Swing Trading Watchlists - mfd.ru
Can Petros Pharmaceuticals Inc. expand its profit marginsAnalyst Downgrade & Low Risk Investment Opportunities - mfd.ru
How Petros Pharmaceuticals Inc. stock valuations compare to rivalsDollar Strength & Step-by-Step Trade Execution Guides - mfd.ru
Why PYT stock is a strong buy callJuly 2025 Gainers & Entry Point Confirmation Alerts - mfd.ru
Is Petros Pharmaceuticals Inc. stock a contrarian buyTake Profit & Fast Gain Swing Alerts - mfd.ru
Aug Levels: What is the next catalyst for Petros Pharmaceuticals IncJuly 2025 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Why IGTR stock attracts HNW investorsJuly 2025 Outlook & AI Powered Market Trend Analysis - mfd.ru
Can Petros Pharmaceuticals Inc. continue delivering strong returnsQuarterly Earnings Report & Safe Entry Point Identification - mfd.ru
AI Stocks: How does Petros Pharmaceuticals Inc perform in inflationary periodsMarket Growth Review & Real-Time Volume Analysis Alerts - baoquankhu1.vn
mfd ru > 2026> Does AMAL stock benefit from AI growthOptions Play & Risk Adjusted Swing Trade Ideas - mfd.ru
Petros Pharmaceuticals Inc (PTPI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.49%
1.78%
자본화:
|
볼륨(24시간):